Document Type : Case report


1 Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran.

2 Clinical Neurology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.


Sneddon syndrome (SS) is characterized by chronic, progressive arteriopathy, which causes ischemic stroke and skin lesions. It seems that thrombotic or embolic processes in the vessels may be involved in the pathology of this syndrome. Neurological symptoms always occur due to the ischemic events of the cerebrovascular system, and the associated cutaneous manifestations include deep blue skin lesions with irregular margins, known as livedo reticularis and livedo racemosa. Despite the ischemic events, hemorrhagic cerebral accidents are unusual in SS. Our case was apparently a normal woman with negative medical history who, despite the normal ischemic cerebral manifestations, initially presented with intracranial hemorrhage, which progressed to new skin lesions (livedo reticularis) after a few days. In the follow-up, the patient was diagnosed with SS.


Sneddon syndrome (SS) is characterized by chronic, progressive arteriopathy, which causes ischemic stroke and skin lesions (1-4). Incidence of SS is reported to be four per a one-million population, and it is known to be more prevalent among young women (1). Although the pathophysiology of SS remains unknown (5), it seems that thrombotic or embolic processes in the vessels may be involved in the occurrence of this syndrome.
Antiphospholipid antibodies are variable in the patients with SS. While ischemic stroke is considered to be the most frequent cerebrovascular complication in SS, some studies have reported other neurological manifestations, such as headaches, seizures, cognitive and psychiatric disturbances, tremor, myelopathy, and encephalopathy (1,2,5,6). In addition, the skin manifestations associated with SS include deep blue skin lesions with irregular margins, known as livedo reticularis (LR) and livedo racemosa. These skin lesions are caused by non-inflammatory vasculopathy and might be detected on the trunk and limbs (3,7,8). The other organs that may be affected by SS are the heart, kidneys, and eyes, giving rise to myocardial, renal, and retinal infarctions. Furthermore, involvement of the cardiovascular system in SS could lead to hypertension and cardiac valve disease (1,9-11).
In this article, we described the case of a 45-year-old woman who, despite the usual ischemic cerebral manifestations, initially presented with intracranial hemorrhage (ICH) and was diagnosed with SS in the follow-up.
Case report
A 45-year-old woman was admitted to the department of neurology for the first time due to headache and slurred speech a few hours prior to her admission. Moreover, the patient had complaints of blurred vision and right-sided weakness in her body. She had no history of recent head trauma or systemic febrile illness. The medical history of the patient revealed no hypertension, infertility, fetal loss, skin disorders or other diseases. Personal, drug use, and family history of the patient were negative as well.
In the physical examination of the patient upon admission, blood pressure was 155/85 mmHg, while the other vital signs (pulse rate, respiratory rate, and temperature) were normal. Although the patient had normal overall mental status, she had influent speech and unilateral (right-sided) hemiparesis. In addition, the right-sided plantar reflex was upward. In the systemic examination, several scattered purple mottling skin rashes (LR) were observed, which were more obvious on the extremities (Figure 1). Otherwise, no significant abnormalities were detected in the general examination of the patient.


Laboratory findings of the patient are presented in Table 1.

According to our observations, C3, C4, cANCA, pANCA, protein C, protein S, antithrombin III, blood urea nitrogen, creatinine, and liver function test were in the normal range. Immunoglobulin electrophoresis showed a normal value as well. In the brain CT-scan and MRI, a massive intraparenchymal brain hemorrhage was detected in the left parietal lobe (Figures 2 & 3).

For further evaluation, brain CT angiography (CTA) and venography (CTV) were performed. Accordingly, the anterior, middle, and posterior cerebral arteries, as well as the vertebra and basilar arteries, showed a normal course with no evidence of narrowing or aneurysmal dilatation. Moreover, no sign of filling defect was observed in the mentioned vessels, and there was no evidence of arteriovenous malformation in the imaging modalities. Brain CTV of the patient was normal as well (Figures 4 & 5).

To evaluate the possible cardiogenic cause of ICH, echocardiography was performed revealing no clue for the embolic source of hemorrhage. Surgical pathology report of the skin lesions was consistent with the possibility of vasculopathic processes. Based on the observed signs and symptoms, the patient was diagnosed with SS and received conservative treatment. One month after discharge, significant improvement was reported in the patient.
After UAE, vaginal examination was performed by gynecologists to confirm control of bleeding. She was discharged 3 days after UAE procedure. At 6 months follow-up, she had regular menstruation without any symptoms of severe vaginal bleeding.

SS is a vasculopathy associated with skin lesions, which was first detected by a dermatologist who reported LR in a patient with multiple ischemic strokes (2). Despite the unknown etiology of SS, it has been established that the syndrome affects the small- and medium-sized arteries. SS is of three types; in the first type, there is no causative factors, while the second type is attributed to antiphospholipid antibodies, and the third type is the systemic lupus erythematosus, which is associated with the presence or absence of antiphospholipid antibodies (1,2,5,7,12).
Several studies have suggested that SS is inherited in an autosomal dominant pattern (13-15). The syndrome is a type of vasculitis presenting with skin lesions and neurological disorders. The lesions include deep blue skin discoloration with irregular margins (LR). Almost in all the cases, SS presents with the ischemic events of the cerebrovascular system, giving rise to headaches (85%), transient ischemic attacks, visual field defects, cognitive impairment and psychiatric problems, hemiplegia, hemianopia, dysarthria, central facial paralysis, seizures, myelopathy, and encephalopathy. Despite the ischemic events, hemorrhagic cerebral accidents are relatively unusual in SS (1,2,4,6,9,10).
SS could also involve the other systems and present with other symptoms than skin and neurological disorders. For instance, SS might affect the cardiovascular system and lead to valvular cardiac problems, especially mitral valve thickening and hypertension (1,10). Moreover, this syndrome may impair the renal function (1) or occlude the central retinal artery and central retinal vein, with subsequent retinal neovascularization (16,17).
Although SS often presents with ischemic cerebrovascular events, our case was a woman who developed hemorrhagic stroke. In addition, she had LR during hospitalization and at the time of ICH occurrence. Some reports confirm the simultaneous incidence of stroke and LR in the patients with SS (1).
As mentioned earlier, SS has various types with or without antiphospholipid antibodies (1,2). Our case showed no associations with these antibodies as the results of investigating the antiphospholipid antibodies were negative twice. Furthermore, there was no evidence of cardiac or renal involvement in the physical and laboratory examinations of the patient. Also, biopsy of the skin lesions was non-specific histologically. In the literature, some reports are focused on the non-specific laboratory findings in SS, which is similar to the patient in the current study. On the other hand, SS diagnosis has mostly been based on the clinical symptoms and complementary paraclinical investigations to document the disease (18).

Inspite of most previous reports, which indicate ischemic stroke as an usual central nervous system manifestation, SS could be presented with hemorrhagic stroke even in the initial phase of presentation.

Hereby, we extend our gratitude to the Center for the Development of Clinical Research at Nemazee Hospital for the support of this research project. We would also like to thank Dr. Nasrin Shokrpour for the editorial assistance.

Conflict of Interest
The authors declare no conflict of interest.

  1. Wu S, Xu Z, Liang H. Sneddon’s syndrome: a comprehensive review of the literature. Orphanet J Rare Dis. 2014;9:215.
  2. Francès C, Papo T, Wechsler B, et al. Sneddon syndrome with or without antiphospholipid antibodies: a comparative study in 46 patients. Medicine (Baltimore). 1999;78:209-219.
  3. Francès C, Piette JC. The mystery of Sneddon syndrome: relationship with antiphospholipid syndrome and systemic lupus erythematosus. J Autoimmun. 2000;15:139-143.
  4. Bottin L, Francès C, de Zuttere D. Strokes in Sneddon syndrome without antiphospholipid antibodies. Ann Neurol. 2015;77:817-829.
  5. Orac A, Artenie A, Toader MP, et al. Sneddon syndrome: rare disease or under diagnosed clinical entity? Review of the literature related to a clinical case. Rev Med Chir Soc Med Nat Iasi. 2014;118:654-660.
  6. Tietjen GE, Al-Qasmi MM, Shukairy MS. Livedo reticularis and migraine: a marker for stroke risk? Headache: Headache. 2002;42:352-355.
  7. Bottin L, Frances C, De Zuttere D, et al. Sneddon Syndrome without Antiphospholipid Antibodies in 55 Cases: Clinical, Radiological and Pathophysiological Features (S43. 005). Neurology. 2012;78: 1 Supplement S43. 005.
  8. Zelger B, Sepp N, Schmid KW, et al. Life history of cutaneous vascular lesions in Sneddon’s syndrome. Hum Pathol. 1992;23:668-675.
  9. Tourbah A, Piette JC, Iba-Zizen MT, et al. The natural course of cerebral lesions in Sneddon syndrome. Arch Neurol. 1997;54:53-60.
  10. Faustino A, Paiva L, Morgadinho A, et al. Cardiac involvement in antiphospholipid syndrome associated with Sneddon syndrome: A challenging diagnosis. Rev Port Cardiol. 2014;33:115.e1-7.
  11. Witmer JP, van Vreeswijk H, Witmer AN. Transient retinal venous and arterial occlusive events in a case of sneddon syndrome. Retin Cases Brief Rep. 2012;6:320-323.
  12. Schellong SM, Weissenborn K, Niedermeyer J, et al. Classification of Sneddon’s syndrome. Vasa. 1997;26:215-221.
  13. Szmyrka-Kaczmarek M, Daikeler T, Benz D, et al. Familial inflammatory Sneddon’s syndrome—case report and review of the literature. Clin Rheumatol. 2005;24:79-82.
  14. Hademenos GJ, Alberts MJ, Awad I, et al. Advances in the genetics of cerebrovascular disease and stroke. Neurology. 2001;56:997-1008.
  15. Rebollo M, Val JF, Garijo F, et al. Livedo reticularis and cerebrovascular lesions (Sneddon’s syndrome). Brain. 1983;106 :965-979.
  16. Pauranik A, Parwani S, Jain S. Simultaneous bilateral central retinal arterial occlusion in a patient with Sneddon syndrome: case history. Angiology. 1987;38:158-163.
  17. Aggermann T, Haas P, Binder S. Central retinal vein occlusion as a possible presenting manifestation of Sneddon syndrome. J Neuroophthalmol. 2007;27:240-241.
  18. Wohlrab J, Fischer M, Wolter M, et al. Diagnostic impact and sensitivity of skin biopsies in Sneddon’s syndrome. A report of 15 cases. Br J Dermatol. 2001;145:285-288.